TXG

10x Genomics, Inc.NASDAQHealthcare

$22.33+1.27%ClosedMarket Cap: $2.85B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	William Blair	—	Outperform	—
2026-03-02	Stifel	—	Buy	—
2026-02-20	UBS	—	Neutral	—
2026-02-13	TD Cowen	—	Hold	—
2026-01-27	Leerink Partners	—	Market Perform	—
2026-01-07	TD Cowen	—	Hold	—
2025-12-22	Canaccord Genuity	—	Buy	—
2025-12-15	Barclays	—	Overweight	—
2025-12-11	Citigroup	—	Neutral	—
2025-12-02	Morgan Stanley	—	Equal Weight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.64	$656.7M	8
Sun Dec 31	$-0.51	$709.0M	10
Mon Dec 31	$-0.37	$777.7M	4
Tue Dec 31	$-0.36	$841.0M	4